Capital International, Inc. Edwards Lifesciences Corp Transaction History

Capital International, Inc.

$7.23 Billion
Q2 2024

A detailed history of Capital International, Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Capital International, Inc. holds 38,206 shares of EW stock, worth $2.5 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

38,206

Previous 81,352 53.04%

Holding current value

$2.5 Million

Previous $7.77 Million 54.6%

% of portfolio

0.05%

Previous 0.11%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$84.3 - $94.31 $3.64 Million - $4.07 Million	-43,146 Reduced 53.04%	38,206 $3.53 Million
Q1 2024 May 14, 2024	SELL	$72.54 - $95.56 $3.62 Million - $4.77 Million	-49,943 Reduced 38.04%	81,352 $7.77 Million
Q4 2023 Feb 13, 2024	SELL	$61.71 - $77.76 $17 Million - $21.4 Million	-275,689 Reduced 67.74%	131,295 $10 Million
Q3 2023 Nov 13, 2023	BUY	$69.28 - $93.38 $1.74 Million - $2.34 Million	25,046 Added 6.56%	406,984 $28.2 Million
Q2 2023 Aug 11, 2023	BUY	$81.41 - $94.33 $3.14 Million - $3.64 Million	38,596 Added 11.24%	381,938 $36 Million
Q1 2023 May 15, 2023	BUY	$74.26 - $84.51 $3.48 Million - $3.96 Million	46,839 Added 15.8%	343,342 $28.4 Million
Q4 2022 Feb 14, 2023	BUY	$68.3 - $87.44 $854,364 - $1.09 Million	12,509 Added 4.4%	296,503 $22.1 Million
Q3 2022 Nov 14, 2022	SELL	$82.37 - $107.29 $22.3 Million - $29.1 Million	-270,859 Reduced 48.82%	283,994 $23.5 Million
Q2 2022 Aug 15, 2022	SELL	$86.5 - $128.27 $456,720 - $677,265	-5,280 Reduced 0.94%	554,853 $52.8 Million
Q1 2022 May 16, 2022	SELL	$101.96 - $128.34 $4.42 Million - $5.57 Million	-43,374 Reduced 7.19%	560,133 $65.9 Million
Q4 2021 Feb 14, 2022	SELL	$106.37 - $130.68 $150,194 - $184,520	-1,412 Reduced 0.23%	603,507 $78.2 Million
Q3 2021 Nov 15, 2021	SELL	$102.91 - $122.75 $7.8 Million - $9.3 Million	-75,768 Reduced 11.13%	604,919 $68.5 Million
Q2 2021 Aug 16, 2021	SELL	$83.84 - $104.76 $2.26 Million - $2.83 Million	-26,998 Reduced 3.81%	680,687 $70.5 Million
Q1 2021 May 14, 2021	SELL	$78.68 - $90.67 $4.32 Million - $4.98 Million	-54,920 Reduced 7.2%	707,685 $59.2 Million
Q4 2020 Feb 16, 2021	BUY	$71.69 - $91.23 $329,487 - $419,293	4,596 Added 0.61%	762,605 $69.6 Million
Q3 2020 Nov 13, 2020	BUY	$67.19 - $87.44 $80,426 - $104,665	1,197 Added 0.16%	758,009 $60.5 Million
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $29.8 Million - $39.9 Million	518,659 Added 217.78%	756,812 $52.3 Million
Q1 2020 May 15, 2020	BUY	$52.41 - $81.0 $859,261 - $1.33 Million	16,395 Added 7.39%	238,153 $44.9 Million
Q4 2019 Feb 18, 2020	BUY	$71.7 - $82.09 $707,965 - $810,556	9,874 Added 4.66%	221,758 $51.7 Million
Q3 2019 Nov 14, 2019	BUY	$61.55 - $75.43 $12.2 Million - $14.9 Million	197,920 Added 1417.36%	211,884 $46.6 Million
Q2 2019 Aug 14, 2019	BUY	$55.74 - $64.41 $778,353 - $899,421	13,964 New	13,964 $2.58 Million

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

470M

Call Options Held

2.44M

Put Options Held

2.65M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.4B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Capital International, Inc. with notifications on news.

Account

Capital International, Inc. Edwards Lifesciences Corp Transaction History